In this study, we investigated the correlation between the tumor gene expression levels of two key regulators of apoptosis—SURVIVIN and MDM2—and the tumor response or clinical outcomes in patients treated with ILP for in-transit melanoma metastases of the limbs. This evidence concerns the gene BIRC5 and melanoma.